These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1364 related articles for article (PubMed ID: 26379392)
1. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. Zhang YC; Xu Z; Zhang TF; Wang YL World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392 [TBL] [Abstract][Full Text] [Related]
2. Serum/plasma microRNAs as biomarkers for HBV-related hepatocellular carcinoma in China. Yin W; Zhao Y; Ji YJ; Tong LP; Liu Y; He SX; Wang AQ Biomed Res Int; 2015; 2015():965185. PubMed ID: 25688372 [TBL] [Abstract][Full Text] [Related]
3. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
4. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs involved with hepatocellular carcinoma (Review). Mao B; Wang G Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882 [TBL] [Abstract][Full Text] [Related]
6. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma. Gailhouste L; Ochiya T Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781 [TBL] [Abstract][Full Text] [Related]
7. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435 [TBL] [Abstract][Full Text] [Related]
9. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713 [TBL] [Abstract][Full Text] [Related]
11. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560 [TBL] [Abstract][Full Text] [Related]
12. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis. Li G; Shen Q; Li C; Li D; Chen J; He M Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842 [TBL] [Abstract][Full Text] [Related]
13. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. Borel F; Konstantinova P; Jansen PL J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424 [TBL] [Abstract][Full Text] [Related]
15. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
16. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model. Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Qi J; Wang J; Katayama H; Sen S; Liu SM Neoplasma; 2013; 60(2):135-42. PubMed ID: 23259781 [TBL] [Abstract][Full Text] [Related]
18. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Chen Y; Chen J; Liu Y; Li S; Huang P Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771 [TBL] [Abstract][Full Text] [Related]
19. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346 [TBL] [Abstract][Full Text] [Related]
20. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Shi T; Morishita A; Kobara H; Masaki T Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]